Publicaciones en colaboración con investigadores/as de Complexo Hospitalario Universitario de Santiago (17)

2022

  1. Integrating digital pathology with transcriptomic and epigenomic tools for predicting metastatic uterine tumor aggressiveness

    Frontiers in Cell and Developmental Biology, Vol. 10

2021

  1. Cancer epigenetic biomarkers in liquid biopsy for high incidence malignancies

    Cancers, Vol. 13, Núm. 12

  2. Characterizing the Invasive Tumor Front of Aggressive Uterine Adenocarcinoma and Leiomyosarcoma

    Frontiers in Cell and Developmental Biology, Vol. 9

  3. Clinical and Histopathologic Characteristics of the Main Causes of Vascular Occlusion — Part I: Thrombi

    Actas Dermo-Sifiliograficas, Vol. 112, Núm. 1, pp. 1-13

  4. Clinical and Histopathologic Characteristics of the Main Causes of Vascular Occusion — Part II: Coagulation Disorders, Emboli, and Other

    Actas Dermo-Sifiliograficas, Vol. 112, Núm. 2, pp. 103-117

  5. Comprehensive cross-platform comparison of methods for non-invasive EGFR mutation testing: results of the RING observational trial

    Molecular Oncology, Vol. 15, Núm. 1, pp. 43-56

  6. Granulomas in Dermatopathology: Principal Diagnoses - Part 1

    Actas Dermo-Sifiliograficas, Vol. 112, Núm. 8, pp. 682-704

  7. Granulomas in Dermatopathology: Principal Diagnoses — Part 2

    Actas Dermo-Sifiliograficas, Vol. 112, Núm. 8, pp. 705-724

2020

  1. Detection of MET Alterations Using Cell Free DNA and Circulating Tumor Cells from Cancer Patients

    Cells, Vol. 9, Núm. 2

  2. Microscopic study of injectable steroids: Effects of postmixing time on particle aggregation

    Pain Physician, Vol. 23, Núm. 4, pp. E417-E424

2016

  1. Mineral metabolism disorders, vertebral fractures and aortic calcifications in stable kidney transplant recipients: The role of gender (EMITRAL study)

    Nefrologia, Vol. 36, Núm. 3, pp. 255-267

2014

  1. Evaluación sistemática de la biopsia de médula ósea en casos de sospecha de mielofibrosis primaria. Propuesta de informe diagnóstico estandarizado. Consenso de expertos de las SEAP/SEHH

    Revista Espanola de Patologia

2011

  1. Consenso de la Sociedad Española de Anatomía Patológica (SEAP) y de la Sociedad Española de Oncología Médica (SEOM) sobre la determinación de HER2 en el carcinoma gástrico

    Revista Espanola de Patologia, Vol. 44, Núm. 1, pp. 32-48

  2. Consensus of the Spanish Society of Medical Oncology (SEOM) and Spanish Society of Pathology (SEAP) for HER2 testing in gastric carcinoma

    Clinical and Translational Oncology, Vol. 13, Núm. 9, pp. 636-651

2009

  1. Guidelines for HER2 testing in breast cancer. A national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

    Revista Espanola de Patologia, Vol. 42, Núm. 1, pp. 3-16

  2. Guidelines for HER2 testing in breast cancer: A national consensus of the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM)

    Clinical and Translational Oncology, Vol. 11, Núm. 6, pp. 363-375

2000

  1. Goodpasture antigen-binding protein, the kinase that phosphorylates the Goodpasture antigen, is an alternatively spliced variant implicated in autoimmune pathogenesis

    Journal of Biological Chemistry, Vol. 275, Núm. 51, pp. 40392-40399